Diagnosis of antiphospholipid antibodies (APA)

Hamostaseologie

Volumn 21, Issue 2, 2001, Pages 54-59

  Triplett, D A ^a  

^a Boll Memorial Hospital   (United States)

Author keywords

Antiphospholipid protein antibodies (APA); Lupus anticoagulants (LA)

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; HIGH MOLECULAR WEIGHT KININOGEN; KININOGEN; LIPOCORTIN 5; LOW MOLECULAR WEIGHT KININOGEN; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; PROTHROMBIN;

ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; BLOOD CLOTTING TEST; COMPLEMENT FIXATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; RADIOIMMUNOASSAY; REVIEW; THROMBOSIS;

EID: 0034929260     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1619509     Document Type: Review

References (30)

1. A primary antiphospholipid syndrome
2. Multiple venous and arterial thromboses associated with the lupus anticoagulant and antibodies to cardiolipin in the absence of SLE
3. Criteria for the diagnosis of lupus anticoagulants: Update
4. A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus
5. A comparison of different test systems in the diagnosis of lupus anticoagulants
6. A sensitive test demonstrating lupus anticoagulant and its behavioral patterns
7. Acquired inhibitors of blood coagulation
8. Antiphospholipid antibodies and thrombosis
9. A survey of 215 non-hemophiliac patients with inhibitors to factor VIII
10. Clinical and serologic features of the antiphospholipid syndrome (APS)
11. Anticardiolipin antibodies detection by radioimmunoassay in association with thrombosis and systemic lupus erythematosus
12. The anticardiolipin syndrome
13. The sensitivity and specificity of commercial reagents for the detection of lupus anticoagulants show marked differences in performance between photo-optical and mechanical coagulometers
14. Observations on the characteristics of an unusual circulating anticoagulant
15. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S. An explanation for their pathogenic mechanism
16. A new serologically active phospholipid from beef heart
17. The Taipan snake venom time: A new test for lupus anticoagulant
18. Autoantibodies to phospholipid-binding plasma proteins: A new view of lupus anticoagulants and other "antiphospholipid" autoantibodies
19. From antiphospholipid syndrome to antibody-mediated thrombosis
20. Acquired inhibitors to the blood coagulation factors
21. Detection of antiphospholipid antibodies by flow cytometry, rapid detection of antibody isotype, and phospholipid specificity
22. The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants
23. Laboratory diagnosis of lupus anticoagulants
24. Many faces of lupus anticoagulants
25. Use of the dilute Russell viper venom time (dRVVT). Its importance and pitfalls
26. A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant identification
27. Lupus anticoagulants: Misnomer, paradox, riddle, epiphenomenon
28. Laboratory diagnosis of lupus and inhibitors: A comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure
29. The textarin/ecarin ratio: A confirmatory test for lupus anticoagulants
30. Eine serodiagnostische reaktion bei syphilis